SARS-Cov2-NP1 (AA 1-180) anticorps
Reactivité: Humain
ELISA, WB
Hôte: Souris
Monoclonal
4C12A6
unconjugated
-
- Antigène
- SARS-Cov2-NP1
- Épitope
- AA 1-180
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Application
- ELISA, Western Blotting (WB)
- Purification
- purified
- Immunogène
- Purified recombinant fragment of human SARS-Cov2-N (AA: 1-180) expressed in E. coli.
- Clone
- 4C12A6
- Isotype
- IgG1
-
- Indications d'application
- WB:1:500 - 1:2000, ELISA:1:10000,
- Restrictions
- For Research Use only
-
- Buffer
- Purified antibody in PBS with 0.05 % sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- 4°C, -20°C for long term storage
-
- Antigène
- SARS-Cov2-NP1
- Sujet
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ The structural proteins of SARS-CoV-2 include the envelope protein (E), spike or surface glycoprotein (S), membrane protein (M) and the nucleocapsid protein (N). The nucleocapsid phosphoprotein is a structural protein that binds to, protects the viral RNA genome and is involved in packaging the RNA into virus particles. The N protein has been suggested as an antiviral drug target.
- Poids moléculaire
- 23 kDa
- ID gène
- 43740575
-
Vous êtes ici:
